Market Closed -
Nasdaq Stockholm
11:29:47 2024-05-17 am EDT
|
5-day change
|
1st Jan Change
|
82.2
SEK
|
-0.96%
|
|
+3.40%
|
+37.92%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,921
|
875.3
|
2,023
|
2,802
|
-
|
-
|
Enterprise Value (EV)
1 |
1,921
|
875.3
|
2,280
|
3,023
|
2,960
|
2,888
|
P/E ratio
|
23.2
x
|
13.1
x
|
12.6
x
|
16.3
x
|
14.9
x
|
13.3
x
|
Yield
|
-
|
-
|
5.03%
|
2.43%
|
2.13%
|
3.65%
|
Capitalization / Revenue
|
-
|
0.61
x
|
1.15
x
|
1.46
x
|
1.36
x
|
1.29
x
|
EV / Revenue
|
-
|
0.61
x
|
1.29
x
|
1.58
x
|
1.44
x
|
1.33
x
|
EV / EBITDA
|
-
|
7.81
x
|
9.48
x
|
11.9
x
|
10.7
x
|
9.44
x
|
EV / FCF
|
-
|
-
|
9.73
x
|
14
x
|
14.3
x
|
11.6
x
|
FCF Yield
|
-
|
-
|
10.3%
|
7.14%
|
6.99%
|
8.66%
|
Price to Book
|
-
|
-
|
7.78
x
|
17.5
x
|
10.5
x
|
8.22
x
|
Nbr of stocks (in thousands)
|
33,702
|
33,861
|
33,942
|
34,091
|
-
|
-
|
Reference price
2 |
57.00
|
25.85
|
59.60
|
82.20
|
82.20
|
82.20
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,443
|
1,766
|
1,916
|
2,059
|
2,172
|
EBITDA
1 |
-
|
112.1
|
240.6
|
255
|
276
|
306
|
EBIT
1 |
-
|
87
|
208.8
|
227
|
246
|
276
|
Operating Margin
|
-
|
6.03%
|
11.82%
|
11.85%
|
11.95%
|
12.71%
|
Earnings before Tax (EBT)
1 |
-
|
89.2
|
210
|
229
|
250
|
280
|
Net income
1 |
91.23
|
68.5
|
163.7
|
179
|
195
|
218
|
Net margin
|
-
|
4.75%
|
9.27%
|
9.34%
|
9.47%
|
10.04%
|
EPS
2 |
2.460
|
1.970
|
4.730
|
5.050
|
5.510
|
6.180
|
Free Cash Flow
1 |
-
|
-
|
234.2
|
216
|
207
|
250
|
FCF margin
|
-
|
-
|
13.26%
|
11.27%
|
10.05%
|
11.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
97.35%
|
84.71%
|
75%
|
81.7%
|
FCF Conversion (Net income)
|
-
|
-
|
143.05%
|
120.67%
|
106.15%
|
114.68%
|
Dividend per Share
2 |
-
|
-
|
3.000
|
2.000
|
1.750
|
3.000
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
334.4
|
329.5
|
349.9
|
429.3
|
393.7
|
-
|
436.9
|
527.9
|
426
|
426
|
442
|
522
|
EBITDA
1 |
25.8
|
20.1
|
25.4
|
40.8
|
44.4
|
-
|
71.2
|
71.3
|
59
|
58
|
68
|
70
|
EBIT
1 |
20.16
|
13.62
|
18.39
|
34.8
|
37.75
|
-
|
64.51
|
59.56
|
52
|
51
|
61
|
62
|
Operating Margin
|
6.03%
|
4.14%
|
5.26%
|
8.11%
|
9.59%
|
-
|
14.76%
|
11.28%
|
12.21%
|
11.97%
|
13.8%
|
11.88%
|
Earnings before Tax (EBT)
1 |
19.9
|
13.3
|
17.9
|
38
|
36.9
|
-
|
67.5
|
59.1
|
53
|
52
|
62
|
63
|
Net income
1 |
15.13
|
10.1
|
14.27
|
28.2
|
29.27
|
36.8
|
53.38
|
44.29
|
41
|
41
|
48
|
49
|
Net margin
|
4.53%
|
3.06%
|
4.08%
|
6.57%
|
7.43%
|
-
|
12.22%
|
8.39%
|
9.62%
|
9.62%
|
10.86%
|
9.39%
|
EPS
|
0.4400
|
0.2900
|
0.4200
|
0.8200
|
0.8500
|
1.060
|
1.560
|
1.260
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/13/22
|
8/26/22
|
11/17/22
|
2/28/23
|
5/12/23
|
8/31/23
|
11/16/23
|
2/27/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
257
|
221
|
158
|
86
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.069
x
|
0.8667
x
|
0.5725
x
|
0.281
x
|
Free Cash Flow
1 |
-
|
-
|
234
|
216
|
207
|
250
|
ROE (net income / shareholders' equity)
|
-
|
-
|
77.2%
|
59%
|
50%
|
44%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
21.9%
|
20%
|
19%
|
19%
|
Assets
1 |
-
|
-
|
746.7
|
895
|
1,026
|
1,147
|
Book Value Per Share
2 |
-
|
-
|
7.660
|
4.700
|
7.800
|
10.00
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +37.92% | 262M | | -.--% | 843M | | +1.57% | 684M | | +33.25% | 486M | | 0.00% | 135M | | +130.43% | 64.29M |
Health Food Stores
|